Jordyn holds a Master of Science degree in Medical Physiology from Stellenbosch University, and specialises in ligand-binding and cell-based immunoassay development and validation. With a strong focus on regulated large molecule pharmacokinetic (PK) and Immunogenicity (ADA and nAb) assessment, Jordyn ensures validations remain aligned with regulatory expectations, while being fit-for-purpose for the generation of clinically relevant data. Additionally, Jordyn oversees the development and validation of all soluble biomarker methods based on Context-of-Use.
Jordyn’s mission is to ensure Synexa always maintains sight of the end goal of bioanalysis, by considering what can be done to make processes and data more patient-centric.